McKesson, CD&R in talks for $5B deal for Option Care Health: FT
According to an FT report, McKesson and CD&R are discussing a $5 billion acquisition deal for Option Care Health.
The current price of $23.37 is positioned between support and resistance levels. As this is a phase where it is necessary to monitor for a potential trend reversal amid sluggish trading volume, split purchasing or cautious entry can be considered alongside M&A acquisition rumor news.
Entering at the current price of $23.37, we will take profit upon reaching the resistance level of $24.88, and cut losses if the support level of $22.29 is breached.
At the entry point, the technical indicators are as follows: RSI(14) is 32.6 (approaching the oversold zone), moving averages are not in a bullish alignment, trading volume is 0.59x of the 20-day average (sluggish), and the 7-day recent volatility rate is -3.0%.
Exceeding the expected modest upward target of 2.5%, it actually recorded a massive surge of 32.6% and received an OVERHIT rating. At the time of entry, amidst an oversold condition with an RSI of 32.6, a non-aligned moving average, and sluggish trading volume amounting to just 0.59 times the 20-day average, it was judged as a wait-and-see market between the support level ($22.29) and resistance level ($24.88). However, a $5 billion acquisition rumor involving McKesson and CD&R immediately led to an actual $5.8 billion acquisition agreement (surging 34%) the next day, acting as a powerful catalyst that instantly overwhelmed the sluggishness of the technical indicators. It is regrettable that we were trapped in a conservative range-bound perspective, failing to more boldly trust the possibility of entering into a material definitive agreement from the 8-K filing (such as Item 1.01) received at the time.
This trade demonstrated that when rumors of a major M&A acquisition coincide with a periodic disclosure (Form 8-K), the disruptive power of momentum can be far greater than expected, even if technical indicators (non-aligned moving averages and sluggish volume) are somewhat weak. Moving forward, if similar M&A-related news or disclosures of significant contracts are detected, we should establish a flexible profit-taking strategy that leaves room for the ripple effects of major events, rather than remaining confined to simple range-bound trading (setting conservative profit-taking criteria).